Early Experience with Tarlatamab (T-Cell Engagers) for Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Canada: Lessons Learned and Implementation Strategies.

Simple Summary: Small cell lung cancer (SCLC) is an aggressive form of lung cancer that often spreads quickly and is hard to treat after initial therapy. Tarlatamab is a new type of immunotherapy, called a T-cell engager, that helps the body's immune system attack cancer cells by targeting a protein...

Descripción completa

Detalles Bibliográficos

Publicado en:	Current Oncology Vol. 31; no. 2; pp. 84 - 111
Autores principales:	Cheema, Parneet K., Perdrizet, Kirstin A., Sangha, Randeep S., Breadner, Daniel, Daaboul, Nathalie, Farley, Shannon, Jao, Kevin, Liu, Geoffrey, Logan, Becky, Melosky, Barbara, Reiman, Anthony, Snow, Stephanie, Yadav, Sunil, Kassam, Shaqil
Formato:	Journal Article
Publicado:	MDPI Feb2026
Acceso en línea:	Ver este registro en EBSCOhost